Literature DB >> 26155848

Time trends, improvements and national auditing of rectal cancer management over an 18-year period.

K Kodeda1, R Johansson2, N Zar3, H Birgisson4, M Dahlberg5, S Skullman6, G Lindmark7, B Glimelius8, L Påhlman4, A Martling9.   

Abstract

AIM: The main aims were to explore time trends in the management and outcome of patients with rectal cancer in a national cohort and to evaluate the possible impact of national auditing on overall outcomes. A secondary aim was to provide population-based data for appraisal of external validity in selected patient series.
METHOD: Data from the Swedish ColoRectal Cancer Registry with virtually complete national coverage were utilized in this cohort study on 29 925 patients with rectal cancer diagnosed between 1995 and 2012. Of eligible patients, nine were excluded.
RESULTS: During the study period, overall, relative and disease-free survival increased. Postoperative mortality after 30 and 90 days decreased to 1.7% and 2.9%. The 5-year local recurrence rate dropped to 5.0%. Resection margins improved, as did peri-operative blood loss despite more multivisceral resections being performed. Fewer patients underwent palliative resection and the proportion of non-operated patients increased. The proportions of temporary and permanent stoma formation increased. Preoperative radiotherapy and chemoradiotherapy became more common as did multidisciplinary team conferences. Variability in rectal cancer management between healthcare regions diminished over time when new aspects of patient care were audited.
CONCLUSION: There have been substantial changes over time in the management of patients with rectal cancer, reflected in improved outcome. Much indirect evidence indicates that auditing matters, but without a control group it is not possible to draw firm conclusions regarding the possible impact of a quality control registry on faster shifts in time trends, decreased variability and improvements. Registry data were made available for reference. Colorectal Disease
© 2015 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Rectal neoplasms; quality control; registries; surgery; therapy

Mesh:

Year:  2015        PMID: 26155848     DOI: 10.1111/codi.13060

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  17 in total

1.  Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.

Authors:  Ipek Sapci; Conor P Delaney; David Liska; Sudha Amarnath; Matthew F Kalady; Scott R Steele; Emre Gorgun
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

2.  Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training.

Authors:  Tania C Sluckin; Sanne-Marije J A Hazen; Karin Horsthuis; Regina G H Beets-Tan; Corrie A M Marijnen; Pieter J Tanis; Miranda Kusters
Journal:  Insights Imaging       Date:  2022-10-20

3.  Pretreatment quality of life in patients with rectal cancer is associated with intrusive thoughts and sense of coherence.

Authors:  Dan Asplund; Thue Bisgaard; David Bock; Jakob Burcharth; Elisabeth González; Eva Haglind; Yanislav Kolev; Peter Matthiessen; Carina Rosander; Jacob Rosenberg; Kenneth Smedh; Marina Åkerblom Sörensson; Eva Angenete
Journal:  Int J Colorectal Dis       Date:  2017-09-14       Impact factor: 2.571

4.  Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.

Authors:  Sara Benitez Majano; Chiara Di Girolamo; Bernard Rachet; Camille Maringe; Marianne Grønlie Guren; Bengt Glimelius; Lene Hjerrild Iversen; Edrun Andrea Schnell; Kristina Lundqvist; Jane Christensen; Melanie Morris; Michel P Coleman; Sarah Walters
Journal:  Lancet Oncol       Date:  2018-12-10       Impact factor: 41.316

5.  Urinary dysfunction in patients with rectal cancer: a prospective cohort study.

Authors:  L Karlsson; D Bock; D Asplund; B Ohlsson; J Rosenberg; E Angenete
Journal:  Colorectal Dis       Date:  2019-08-07       Impact factor: 3.788

6.  Lateral Lymph Node Metastases in Locally Advanced Low Rectal Cancers May Not Be Treated Effectively With Neoadjuvant (Chemo)Radiotherapy Only.

Authors:  Anouck Haanappel; Hidde M Kroon; Dennis P Schaap; Sergei Bedrikovetski; Nagendra N Dudi-Venkata; Hong X Lee; Michelle L Thomas; Jianliang Liu; Maxime J M van der Valk; Harm J T Rutten; Geerard L Beets; Miranda Kusters; Tarik Sammour
Journal:  Front Oncol       Date:  2019-12-03       Impact factor: 6.244

7.  Survival in colon and rectal cancers in Finland and Sweden through 50 years.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki
Journal:  BMJ Open Gastroenterol       Date:  2021-07

8.  The importance of rectal washout for the oncological outcome after Hartmann's procedure for rectal cancer: analysis of population-based data from the Swedish Colorectal Cancer Registry.

Authors:  F Jörgren; R Johansson; H Arnadottir; G Lindmark
Journal:  Tech Coloproctol       Date:  2017-05-30       Impact factor: 3.781

9.  Self-reported sexual dysfunction in patients with rectal cancer.

Authors:  M Sörensson; D Asplund; P Matthiessen; J Rosenberg; T Hallgren; C Rosander; E González; D Bock; E Angenete
Journal:  Colorectal Dis       Date:  2019-12-06       Impact factor: 3.788

10.  Defunctioning Stomas Result in Significantly More Short-Term Complications Following Low Anterior Resection for Rectal Cancer.

Authors:  Andrew Emmanuel; Ezzat Chohda; Christo Lapa; Andrew Miles; Amyn Haji; Joe Ellul
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.